生物标志物
细胞损伤
医学
冠状病毒
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
病理
生物
程序性细胞死亡
2019-20冠状病毒爆发
遗传学
细胞凋亡
疾病
爆发
传染病(医学专业)
作者
Temesgen E. Andargie,Takayuki Tsuji,Fayaz Seifuddin,Moon Kyoo Jang,Peter S.T. Yuen,Hyesik Kong,Ilker Tunc,Komudi Singh,Ananth Charya,Kenneth J. Wilkins,Steven D. Nathan,Andrea L. Cox,Mehdi Pirooznia,Robert A. Star,Sean Agbor‐Enoh
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2021-04-08
卷期号:6 (7)
被引量:86
标识
DOI:10.1172/jci.insight.147610
摘要
INTRODUCTION. The clinical course of coronavirus 2019 (COVID-19) is heterogeneous, ranging from mild to severe multiorgan failure and death. In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories.
科研通智能强力驱动
Strongly Powered by AbleSci AI